Side-effects of generic

Area of Science:

• Psychiatry and Pharmacology
• Health Economics
• Clinical Pharmacy

Background:

• Healthcare systems increasingly focus on pharmacoeconomics to reduce treatment costs.
• This trend extends to psychiatric practice, where cost-saving measures are being explored.
• General practitioners (GPs) are permitted to substitute prescribed medications with cheaper, equally effective alternatives within the same drug class.

Observation:

• A 74-year-old male patient with psychotic depression experienced two hospitalizations due to exogenic factors.
• Introduction of risperidone following the second hospitalization resulted in a long-term remission lasting several years.
• Despite a stable psychopharmacological regimen, a new illness episode emerged.

Findings:

• The relapse occurred despite consistent psychopharmacological dosing.
• Investigation revealed the pharmacist had dispensed a generic version of risperidone instead of the original brand-name medication.
• The generic was of an equivalent dose, suggesting potential differences in formulation or bioavailability impacting clinical outcomes.

Implications:

• This case underscores the potential clinical impact of generic drug substitution in psychiatric treatment.
• Pharmacoeconomic strategies must carefully balance cost reduction with maintaining therapeutic efficacy.
• Further research is warranted to explore the clinical significance of generic-to-brand or brand-to-generic switches for psychotropic medications.